Kil-Nam Kim

Dr. Kil-Nam Kim

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in Fish & Shellfish Immunology
Verified
Journal Article
Closed access
EKEun-Yi Ko
Eun-Yi Ko
SCSu-Hyeon Cho
Su-Hyeon Cho
SKSeung-Hae Kwon
Seung-Hae Kwon
CEChi-Yong Eom
Chi-Yong Eom
MJMyeong Seon Jeong
Myeong Seon Jeong
Kil-Nam KimKil-Nam Kim
Kil-Nam Kim

28 January 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Kandasamy SaravanakumarKandasamy Saravanakumar
Kandasamy Saravanakumar
SPSeonJu Park
SeonJu Park
Anbazhagan SathiyaseelanAnbazhagan Sathiyaseelan
Anbazhagan Sathiyaseelan
Kil-Nam KimKil-Nam Kim
Kil-Nam Kim
SCSu-Hyeon Cho
Su-Hyeon Cho
MWMyeong-Hyeon Wang
Myeong-Hyeon Wang
In this study, the methanolic extract from seeds of Gardenia jasminoides exhibited strong antioxidant and enzyme inhibition activities with less toxicity to NIH3T3 and HepG2 cells at the concentration of 100 µg/mL. The antioxidant activities (DPPH and ABTS), α-amylase, and α-glucosidase inhibition activities were found higher in methanolic extract (MeOH-E) than H2O extract. Besides, 9.82 ± 0.62 µg and 6.42 ± 0.26 µg of MeOH-E were equivalent to 1 µg ascorbic acid for ABTS and DPPH scavenging, respectively while 9.02 ± 0.25 µg and 6.52 ± 0.15 µg of MeOH-E were equivalent to 1 µg of acarbose for inhibition of α-amylase and α-glucosidase respectively. Moreover, the cell assay revealed that the addition of MeOH-E (12.5 µg/mL) increased about 37% of glucose uptake in insulin resistant (IR) HepG2 as compared to untreated IR HepG2 cells. The LC- MS/MS and GC-MS analysis of MeOH-E revealed a total of 54 compounds including terpenoids, glycosides, fatty acid, phenolic acid derivatives. Among the identified compounds, chlorogenic acid and jasminoside A were found promising for anti-diabetic activity revealed by molecular docking study and these molecules are deserving further purification and molecular analysis.

4 June 2023 in Marine Drugs
Verified
Journal Article
Open access
PDF file
AJArachchige Maheshika Kumari Jayasinghe
Arachchige Maheshika Kumari Jayasinghe
KKKirinde Gedara Isuru Sandanuwan Kirindage
Kirinde Gedara Isuru Sandanuwan Kirindage
Ilekuttige Priyan Shanura FernandoIlekuttige Priyan Shanura Fernando
Ilekuttige Priyan Shanura Fernando
Kil-Nam KimKil-Nam Kim
Kil-Nam Kim
JOJae Young Oh
Jae Young Oh
GAGinnae Ahn
Ginnae Ahn
Brown seaweed is a rich source of fucoidan, which exhibits a variety of biological activities. The present study discloses the protective effect of low molecular weight fucoidan (FSSQ) isolated from an edible brown alga, Sargassum siliquastrum, on lipopolysaccharide (LPS)-stimulated inflammatory responses in RAW 264.7 macrophages. The findings of the study revealed that FSSQ increases cell viability while decreasing intracellular reactive oxygen species production in LPS-stimulated RAW 264.7 macrophages dose-dependently. FSSQ reduced the iNOS and COX-2 expression, inhibiting the NO and prostaglandin E2 production. Furthermore, mRNA expression of IL-1β, IL-6, and TNF-α was downregulated by FSSQ via modulating MAPK and NF-κB signaling. The NLRP3 inflammasome protein complex, including NLRP3, ASC, and caspase-1, as well as the subsequent release of pro-inflammatory cytokines, such as IL-1β and IL-18, release in LPS-stimulated RAW 264.7 macrophages was inhibited by FSSQ. The cytoprotective effect of FSSQ is indicated via Nrf2/HO-1 signaling activation, which is considerably reduced upon suppression of HO-1 activity by ZnPP. Collectively, the study revealed the therapeutic potential of FSSQ against inflammatory responses in LPS-stimulated RAW 264.7 macrophages. Moreover, the study suggests further investigations on commercially viable methods for fucoidan isolation.

21 July 2019 in Nanomaterials
Verified
Journal Article
Open access
PDF file
Woo-Ju SongWoo-Ju Song
Woo-Ju Song
MJMyeong Seon Jeong
Myeong Seon Jeong
DCDong-Min Choi
Dong-Min Choi
Kil-Nam KimKil-Nam Kim
Kil-Nam Kim
MWMyung-Bok Wie
Myung-Bok Wie
The present study examined the potential toxic concentrations of zinc oxide nanoparticles (ZnO NPs) and associated autophagy and apoptosis-related injuries in primary neocortical astrocyte cultures. Concentrations of ZnO NPs ≥3 μg/mL induced significant toxicity in the astrocytes. At 24 h after exposure to the ZnO NPs, transmission electron microscopy revealed swelling of the endoplasmic reticulum (ER) and increased numbers of autophagolysosomes in the cultured astrocytes, and increased levels of LC3 (microtubule-associated protein 1 light chain 3)-mediated autophagy were identified by flow cytometry. Apoptosis induced by ZnO NP exposure was confirmed by the elevation of caspase-3/7 activity and 4′,6′-diamidino-2-phenylindole (DAPI) staining. Significant (p < 0.05) changes in the levels of glutathione peroxidase, superoxide dismutase, tumor necrosis factor (TNF-α), and interleukin-6 were observed by enzyme-linked immunoassay (ELISA) assay following the exposure of astrocyte cultures to ZnO NPs. Phosphatidylinositol 3-kinase (PI3K)/mitogen-activated protein kinase (MAPK) dual activation was induced by ZnO NPs in a dose-dependent manner. Additionally, the Akt (protein kinase B) inhibitor BML257 and the mTOR (mammalian target of rapamycin) inhibitor rapamycin contributed to the survival of astrocytes. Inhibitors of cyclooxygenase-2 and lipoxygenase attenuated ZnO NP-induced toxicity. Calcium-modulating compounds, antioxidants, and zinc/iron chelators also decreased ZnO NP-induced toxicity. Together, these results suggest that ZnO NP-induced autophagy and apoptosis may be associated with oxidative stress and the inflammatory process in primary astrocyte cultures.

1 June 2021 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
Mawalle Kankanamge Hasitha Madhawa DiasMawalle Kankanamge Hasitha Madhawa Dias
Mawalle Kankanamge Hasitha Madhawa Dias
DMDissanayaka Mudiyanselage Dinesh Madusanka
Dissanayaka Mudiyanselage Dinesh Madusanka
EHEui Jeong Han
Eui Jeong Han
HKHyun Soo Kim
Hyun Soo Kim
You-Jin JeonYou-Jin Jeon
You-Jin Jeon
GAGinnae Ahn
Ginnae Ahn

1 May 2020 in International Immunopharmacology
Verified
Journal Article
Closed access
SCSu-Hyeon Cho
Su-Hyeon Cho
HKHyun-Soo Kim
Hyun-Soo Kim
WLWonWoo Lee
WonWoo Lee
EHEui Jeong Han
Eui Jeong Han
SKSeo-Young Kim
Seo-Young Kim
Kil-Nam KimKil-Nam Kim
Kil-Nam Kim